|Day Low/High||8.19 / 8.64|
|52 Wk Low/High||8.25 / 25.96|
Warren Buffett's Berkshire Hathaway increases its stake in the drugmaker to 43.2 million shares from 40.5 million shares at the end of March.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.
The animal health market continues to be strong, and so is the outlook. Here are several plays on the space and why you should make them.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2018.
U.S. stock futures trade lower on Thursday,, sparked by a tougher stance on China tariffs from the White House; Tesla jumps as revenue tops forecasts; Starbucks partners with Alibaba for a delivery business in China.
Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) published its annual social impact report, highlighting achievements related to the two pillars that drive the Company's initiatives: building healthy communities and leading a responsible...
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its second quarter 2018 financial results on Thursday, August 2, 2018 at 7:00 a.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Uceris ®1 (budesonide) extended-release tablets, 9 mg, in the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced 23 abstracts, one late-breaking poster and three oral presentations of fremanezumab for the preventive treatment of migraine which will be presented at the American Headache...
Despite a growing trade war between the U.S, and China, drug officials in that country have pledged to try to stop the flow of fentanyl into the U.S.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a change in the clinical development program of fremanezumab in chronic cluster headache.
A healthcare bill supported on both sides of the aisle was held up until Sen. Chuck Grassley talked with pharma companies.
Following up on a pledge to accelerate generic drugs into the marketplace to stoke price competition, the agency signals pending reform of the Risk Evaluation and Mitigation Strategy.
Jim Cramer weighs in on Sirius XM Radio, Teva Pharmaceuticals, iQIYI, Blue Apron, Shopify, Incyte, E*Trade Financial and more.
Jim Cramer tells investors to keep their eyes open for companies making changes -- that's what's being rewarded.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today confirmed that the U.
Here's what you need to know now for Friday, May 18.
Aimovig is the first treatment approved by the agency to prevent migraines by blocking the calcitonin gene-related peptide receptor.
The Dow, S&P 500 and Nasdaq all rose on Wednesday.
Berkshire Hathaway hiked its stake in the drugmaker, which is undergoing a restructuring, to 40.5 million shares as of the end of March.
First bulleted paragraph, second sentence of release dated May 15, 2018 should contain the numbers 4.
The Israel-based drugmaker reported first-quarter numbers that surpassed analysts' expectations but Wall Street wants to see more.
Shares of Tesla Inc., which reported earnings on Wednesday, fell by 5.5%
Teva shares edged into positive territory for the year Thursday after a stronger-than-expected start to the year allowed CEO Kåre Schultz to boost the generic drugmaker's 2018 earnings forecast.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended March 31, 2018.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced new scientific abstracts for AUSTEDO ® (deutetrabenazine) tablets will be presented at the American Psychiatric Association (APA) 2018 Annual Meeting in New York from May 5-9.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE ® (glatiramer...
Jim Cramer shines a spotlight on McDonald's, Nucor, Ball Corp. United States Steel, Teva Pharmaceuticals, Chicago Mercantile Exchange and more.
Jim Cramer says he's still optimistic, and he doesn't want investors to give up. But he has 12 reasons to also remain cautious -- especially about Fridays.
The tough news keeps coming at the generic drug company, which announced last week it was considering putting itself up for sale. Now the Justice Department wants a chat.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.